Back

Hyponatremia and risk of new-onset heart failure in patients with type 2 diabetes - a real-world study of 70,000 patients

2 September 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: Specific underlying diseases of heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Mads Jensen

Herlev Hospital, Herlev (Denmark)

7 More presentations in this session

Presentation thumbnail
Prognostic impact of myocarditis as aetiology compared with dilated cardiomyopathy and ischaemic heart disease in heart failure
Professor M. Fu (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Time-varying cox model for heart failure prediction in phospholamban p.(Arg14del)-positive individuals
Miss M. Van Der Heide (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Adverse prognostic implications of increased left ventricular force in hypertrophic cardiomyopathy
Professor K. Wierzbowska-Drabik (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Clinical and genetic profiles of patients with hereditary and wild type transthyretin amyloidosis: the transthyretin cardiac amyloidosis registry in the state of Sao Paulo, Brazil REACT-SP
Assistant Professor F. Fernandes (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Is the incidence of cerebral embolic events underestimated in Takotsubo cardiomyopathy?
Doctor M. Ilinca (Sherbrooke, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Specific underlying diseases of heart failure

The Event

Event poster

ESC Congress 2024

2 September 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Hyponatremia is highly prevalent and associated with worse clinical outcomes in HF population in Turkiye: results from TRends-HF
thumbnail
Congress Presentation
Spot urinary sodium in outpatients with chronic heart failure. A longitudinal analysis.
thumbnail
Congress Presentation
The underestimated risk of prediabetes on cardiovascular and renal outcomes in patients with heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources